<DOC>
	<DOCNO>NCT01618279</DOCNO>
	<brief_summary>The main aim study evaluate difference serum level tryptase study population . Will select number 350 patient hospitalized coronary heart disease .</brief_summary>
	<brief_title>Tryptase Coronary Heart Disease</brief_title>
	<detailed_description>A series scientific study evaluate tryptase biomarker coronary plaque instability , course ischemic heart disease . Among , recent 'outcome ' well define Meixiang Xiang study , conduct 2011 270 patient . This study evaluate compare level tryptase four population : 1. acute myocardial infarction ( 31 subject ) 2. unstable angina ( 108 subject ) 3. stable angina ( 36 subject ) 4. coronary artery disease coronary stenosis &lt; 50 % ( 95 subject ) . In Chinese population final evaluation lead define tryptase marker independent instability atheromatous plaque . In reference fact still correlation tryptase coronary plaque instability clinical symptom , propose verification study role tryptase biomarker acute coronary condition study large population Italian subject acute phase pathology follow . The work conduct 4 patient population : 1. acute coronary syndrome ST elevation electrocardiogram ; 2. acute coronary syndrome without ST elevation electrocardiogram ( acute myocardial infarction ST-segment depression electrocardiogram unstable angina ) 3. noncritical coronary artery disease coronary stenosis &lt; 50 % ; 4. aortic aneurysm . Secondary endpoint evaluate role tryptase event major cardiovascular event .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>male female subject age 18 80 year patient clinical manifestation discover document symptom coronary heart disease patient characteristic necessarily sign informed consent inclusion study patient allergy symptoms place ( hive , uncontrolled asthma ) autoimmune disease , mastocytosis , hypereosinophilia , myelodysplastic syndrome , cancer , kidney failure deny consent participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>tryptase</keyword>
	<keyword>coronary</keyword>
	<keyword>stemi</keyword>
	<keyword>nstemi</keyword>
</DOC>